The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT03001167
This cross-disciplinary study will assemble and longitudinally follow a large, diverse birth cohort to determine the relationships between early life antibiotic exposure, microbiome development, growth, antibodies, and immunostimulation.
Looking for future studies?
Notify MeUp to 96 hour
All sexes
Observational
Philadelphia, Pennsylvania, 19104, United States
Perinatal and infant antibiotic exposures are common and have been linked to changes in the gut microbiome, which plays a central role in health and disease. Childhood obesity is an epidemic and animal models have linked antibiotic induced changes in the microbiome with increased adiposity. Infants become colonized with trillions of bacteria in the first few hours of life. During this time period, their nascent immune system develops tolerance to commensal microbes
The primary objectives are to measure the impact of common perinatal and early childhood antibiotic exposures on the structure and function of the developing gut microbiome. To determine the association between common perinatal and early childhood antibiotic exposures and weight/adiposity gain in a large birth cohort of children. To determine mechanisms for the association between microbiome changes over time and the rate of weight/adiposity gain in a large birth cohort of children. To determine the normal developmental pattern by which healthy children develop antibodies in their blood against the microbes that naturally colonize their intestines. To determine the association between immunostimulation and protection from persistent colonization in humans.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(if not specified, applies to child):
Exclusion criteria
(if not specified, applies to child):
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Skinfolds at the triceps are measured (0.1 mm) with a skinfold caliper
Time frame: 24 months
Skinfolds at the superiliac and subscapular sites are measured (0.1 mm) with a skinfold caliper
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Children's Hospital of Philadelphia
Other
Early Life Antibiotics, Gut Microbiome Development, and Risk of Childhood Obesity
Acronym: MAGIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07227220
Behavior, Behavior, Health
Houston, Texas, United States
View Trial DetailsNCT05994924
Body Weight, Nutrition Disorders
Winston-Salem, North Carolina, United States
View Trial DetailsNCT04873245
Body Weight, Nutrition Disorders
Minneapolis, Minnesota, United States
View Trial DetailsNCT05416125
Body Weight, Nutrition Disorders
Minneapolis, Minnesota, United States
View Trial Details